At Appriss Health, we feel the responsibility and obligation to always communicate with patients and put them at the forefront when we design solutions.
We have spent years developing clinical decision support tools for healthcare providers and pharmacists to make better informed decisions. In doing so, we have obtained the feedback from countless medical professionals, including many pain providers. Through these providers we have heard (directly and indirectly) from many chronic pain patients as well. We have taken and continue to take all feedback from both medical professionals and patients very seriously. As we continue to develop and design solutions, patients will remain at the heart of what we do.
We know that seeing a doctor often means that you are not feeling well and you are concerned about your condition and treatment plan.
Part of your treatment plan, whether it is short-term, or long-term, may, or may not, include the use of prescription medications. Your doctor(s) may have been required to, or opted to, check the state prescription drug monitoring program (PDMP) to evaluate risk factors, including your prescription history over the last year or two. Some PDMPs include a NarxCare Report which is a specially designed PDMP report that helps your doctor better understand the information in the PDMP.
To learn more about this report and other frequently asked questions about NarxCare, we encourage you to download our information sheet for patients and families.
Often patients are cared for in large practice groups and have little say in who exactly they see from visit to visit. Through data support and analytics, our solutions enable healthcare providers to make better informed prescribing decisions when coordinating care for a patient.
To learn more about how we provide knowledge for good, we encourage you to read our blog series “A Balanced Approach to Opioids and Chronic Pain.” In this series we explore our approach to benefit/risk assessment, data presentation, and clinical support…and how they relate to our goal of creating a usable and balanced clinical viewpoint that protects access to care while highlighting areas of risk that clinicians and patients should be aware of.
In Part I, we explore the risks and benefits of opioid use for chronic pain.
In Part II, we define risk as it relates to the use of opioids.
In Part III, we discuss what a conversation between a patient and doctor might look like when treating a patient in pain and considering opioids.
In Part IV, we discuss what information is in a PDMP report and how providers should use it.
In Part V, we discuss the multiple provider episodes metric, one of many metrics clinicians use to assess risk when treating a patient in pain and considering opioids.
In Part VI, we discuss how visualization and graphing of PDMP data helps clinicians see important patterns.
In Part VII, we discuss how PDMP visuals only tell part of the story and why details matter.
In Part VIII, we discuss how PDMP data is scored and why you should “never treat a number.”
In Part IX, we explain Appriss Health’s approach to scoring PDMP Data.
In Part X, we explain how Appriss Health uses machine learning to help better predict the risk of overdose by using PDMP data.
In Post XI, we bring the series to a close by offering some final thoughts on benefit and risk.
Please use this form to contact us and let us know how we may be of further assistance. We will route your request to the right person and get back to you. Thank you.